Institutional Review Board, Hospital for Special Surgery
July 21, 2021
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
Karmela Kim Chan, MD
Anne R. Bass, MD
Vivian Bykerk, MD
Susan Goodman, MD
This is a registry, without any intervention.
Patients who are referred to HSS rheumatology for mangement of adverse events arising from cancer immunotherapy are elibible for enrollment into the registry.
Diviya Rajesh
RajeshD@hss.edu
646.797.8639